Head-to-head
NexLife vs Amble Health
Compared on tirzepatide across the eight dimensions this database records. They differ on 4 of those eight. NexLife is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
NexLife is $129 a month all-in for tirzepatide; Amble Health is $300. Over twelve months that is $1,380 against $3,600. Value Scores are 96.1 and 57.1 out of 100.
Tirzepatide
Plan pages: NexLife plans · Amble Health plans
At 10 mg/week, NexLife is $129 a month all-in and Amble Health is $300 — $171 apart, or $2,052 across a year. Over twelve months the totals are $1,380 (12-month plan) and $3,600 (billed monthly).
NexLife charges a flat $129 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
Amble Health charges a flat $300 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
| Dose | NexLife | Amble Health | Cheaper |
|---|---|---|---|
| 2.5 mg | $129 | $300 | NexLife by $171 |
| 5 mg | $129 | $300 | NexLife by $171 |
| 7.5 mg | $129 | $300 | NexLife by $171 |
| 10 mg | $129 | $300 | NexLife by $171 |
| 12.5 mg | $129 | $300 | NexLife by $171 |
| 15 mg | $129 | $300 | NexLife by $171 |
NexLife is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, the field median is $299 a month all-in. NexLife, at $129, is $170 below it; Amble Health, at $300, is $1 above it.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide price in this database, is $449 a month at 10 mg/week — NexLife is $320 below it and Amble Health is $149 below it. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | NexLife | Amble Health | Cheaper |
|---|---|---|---|
| Month to month | $129 | $300 | NexLife by $171 |
| 3-month term | $125 | — | only NexLife publishes this term |
| 6-month term | $119 | — | only NexLife publishes this term |
| 12-month term | $115 | — | only NexLife publishes this term |
| Settled dose | NexLife | Amble Health | Difference |
|---|---|---|---|
| 2.5 mg | $1,548 | $3,600 | $2,052 apart |
| 5 mg | $1,548 | $3,600 | $2,052 apart |
| 7.5 mg | $1,548 | $3,600 | $2,052 apart |
| 10 mg | $1,548 | $3,600 | $2,052 apart |
| 12.5 mg | $1,548 | $3,600 | $2,052 apart |
| 15 mg | $1,548 | $3,600 | $2,052 apart |
Amble Health publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $1,548 on NexLife and $3,600 on Amble Health. Both programs charge one flat rate, so the ramp costs the same as any other stretch of the year.
Value Scores are 96.1 for NexLife and 57.1 for Amble Health, against a tirzepatide category floor of $126. NexLife leads by 39.0 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| NexLife | 68.4 | 12.8 | 10 | 5 | 96.1 |
| Amble Health | 29.4 | 12.8 | 10 | 5 | 57.1 |
Where the two programs differ
All-in monthly
NexLife is cheaper month to month — $129 against $300, a gap of $171 every month, or $2,052 across a year if both rates hold.
Cancellation terms
Cancellation differs: NexLife states Cancellations take effect after 30 days, so one additional shipment may be charged (plan pages), while Amble Health states Cancel before renewal. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
NexLife asks for None on month to month; 3-, 6- and 12-month plans start only if prescribed, and unshipped months are refunded if treatment stops; Amble Health asks for Month-to-month. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Twelve-month cost
Over twelve months the totals are $1,380 for NexLife and $3,600 for Amble Health. NexLife is lower by $2,220 — a figure worth checking against the cancellation terms below, because a longer plan is only cheaper if you stay on it.
Dose policy
Both hold one price across the whole dose ladder, so neither punishes titration and the monthly figures above are what you actually pay at 15 mg as well as at 2.5 mg.
Evidence status
Both figures carry the same evidence status, provider-stated: taken from the provider's own published pages; checkout capture pending. Neither is stronger than the other on provenance.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
NexLife Official site
NexLife sells compounded tirzepatide and semaglutide at one price at every dose, with no membership fee. The price includes provider review and medical guidance (NexLife Medical Group), a personalized GLP-1 nutrition plan, a 1:1 call with a certified wellness coach, 24/7 support and free expedited shipping. Labs are not listed as included.
It names its compounding pharmacy — Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL), Boudreaux's New Drug Store (Lake Charles, LA), recorded as State-licensed 503A compounding pharmacies (named on plan pages) — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None on month to month; 3-, 6- and 12-month plans start only if prescribed, and unshipped months are refunded if treatment stops; cancellation is Cancellations take effect after 30 days, so one additional shipment may be charged (plan pages); availability is stated as All 50 US states where affiliated providers are licensed.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — nexlife.us plan pages, read 2026-11-06
Watch: Plans continue monthly unless canceled, and a cancellation takes effect after 30 days, so one more shipment may be charged. NexLife's refund policy page covers program fees, not medication, for members who lose less than 5% of starting weight over 180 days, with conditions. Provider-stated from nexlife.us plan pages read November 6, 2026; checkout capture pending.
Amble Health Official site
A no-membership program with $300/month flat tirzepatide.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Availability at intake.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — amblehealth.com pricing capture 2026-08-05
Watch: Provider-stated; checkout capture pending.
Which molecules each one carries
NexLife carries tirzepatide at $129 a month and semaglutide at $109 a month.
Amble Health carries tirzepatide at $300 a month; does not offer semaglutide.
Comparable only on tirzepatide: they do not both publish a rankable semaglutide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
NexLife does not publish
- no state-by-state availability list — it says All 50 US states where affiliated providers are licensed
Amble Health does not publish
- no published twelve-month tirzepatide rate
- no named compounding pharmacy
Ask NexLife and Amble Health for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. NexLife carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Plan length moves the annual figures. NexLife publishes a twelve-month rate of $115 a month against $129 month to month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lower standing monthly rate for tirzepatide, NexLife Official site wins this matchup. And if you would rather trust a better-evidenced number, amble health's price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. NexLife's tirzepatide price is provider-stated as of 2026-11-06; Amble Health's is provider-stated as of 2026-08-05.
Questions
Is NexLife or Amble Health cheaper for tirzepatide?
NexLife is cheaper on all-in monthly cost at 10 mg/week: $129 against $300, a difference of $171 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of NexLife versus Amble Health?
NexLife works out to $1,380 across twelve months and Amble Health to $3,600, on the plan terms each publishes.
Does NexLife or Amble Health raise the price as the dose goes up?
NexLife: no, it charges one flat rate at every dose. Amble Health: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do NexLife and Amble Health differ?
4 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of NexLife and Amble Health names its pharmacy?
NexLife does — Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL), Boudreaux's New Drug Store (Lake Charles, LA). Amble Health does not, recording only Partner pharmacies, so who makes its medication cannot be independently verified.
How well evidenced are the NexLife and Amble Health prices?
NexLife's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-11-06. Amble Health's is provider-stated, captured 2026-08-05. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: NexLife official site · Amble Health official site. Compounded tirzepatide and semaglutide are not FDA-approved products.